ABT vs PHIN · P/E 25, rev $44.33B vs P/E 27, rev $3.48B
Abbott Laboratories (ABT) versus PHINIA Inc. (PHIN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
PHINIA Inc. (PHIN) is a auto parts company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PHIN revenue for 2025-12-31 was $3.48B. Net income was $130.0M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. PHIN currently screens at market cap $1.88B and trailing P/E 26.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PHIN currently screens at market cap $1.88B and trailing P/E 26.8.
Not investment advice. Open the ABT and PHIN stock pages for the full models.
Not investment advice.